MELD Exceptions and Rates of Waiting List Outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MELD Exceptions and Rates of Waiting List Outcomes

Published:2011-09-15 Issue:11 Volume:11 Page:2362-2371
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Massie A. B.,Caffo B.,Gentry S. E.,Hall E. C.,Axelrod D. A.,Lentine K. L.,Schnitzler M. A.,Gheorghian A.,Salvalaggio P. R.,Segev D. L.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2011.03735.x/fullpdf

Reference20 articles.

1. A model to predict survival in patients with end-stage liver disease;Kamath;Hepatology,2001

2. New national liver transplant allocation policy: Is the regional review board process fair;Voigt;Liver Transplant,2004

3. Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula;Freeman;Liver Transplant,2006

4. Regional variations in peer reviewed liver allocation under the MELD system;Rodriguez-Luna;Am J Transplant,2005

5. Model for end-stage liver disease (MELD) exception guidelines;Wiesner;Liver Transplant,2006

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic Exception Points for Fair Liver Allocation;Service Science;2024-06-10

2. Continuous Risk Score Predicts Waitlist and Post-transplant Outcomes in Hepatocellular Carcinoma Despite Exception Changes;Clinical Gastroenterology and Hepatology;2024-06

3. Waitlist Outcomes for Exception and Non-exception Liver Transplant Candidates in the United States Following Implementation of the Median MELD at Transplant (MMaT)/250-mile Policy;Transplantation;2024-03-29

4. The future of liver transplantation;Hepatology;2024-03-27

5. Impact of Median MELD at Transplant Minus 3 National Policy on Quality of Transplanted Livers for Patients With and Without Hepatocellular Carcinoma;Transplantation;2023-12-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3